Reports

Ideas That Generate Results

Global Insulin Delivery Devices Market Outlook 2018

Global Insulin Delivery Devices Market Outlook 2018

Format :  Adobe Reader (PDF) Upto 24 hour delivery
Publish Date : Nov, 2014| No. of Pages : 120

Share |
 
Please make your selection :
Electronic Access - Single User License
US$ 1300.00
CD-ROM Mail Delivery
US$ 1500.00
Hard Copy Mail Delivery
US$ 1500.00
Electronic Access - Multi-User License
US$ 1800.00

In 2013, a total of 382 Million People had diabetes and by 2030 this number is expected to rise to 552 Million. This finding by the International Diabetes Federation (IDF) and similar results from studies done by organizations of repute such as WHO, CDC, NHS, etc., suggest that a huge patient population exists in the diabetes market. In 2013, health expenditure on diabetes accounted for around 10% of the total health expenditure globally. Of all the market segments that result from this multibillion dollar expenditure, insulin delivery devices represents one of the most rapidly expanding areas and is thus the key focus of RNCOS’ current study.

In our latest research study “Global Insulin Delivery Devices Market Outlook 2018”, RNCOS’ analysts identified the market dynamics in various important regions to highlight the areas offering promising opportunities to companies for boosting their growth. The market, which stood at US$ 10.4 Billion in 2013, is expected to grow at a CAGR of 8.5% during 2013-2018.

Insulin delivery devices predominantly include Insulin Syringes, Insulin Pens (Disposable and Reusable), Insulin Pumps and Insulin Jet Injectors. Our study provides a comprehensive analysis of the delivery devices market, both at global and regional levels. This analysis includes the current market statistics, key drivers stimulating each segment’s growth, and the future outlook of the segments. The analysis will help readers to assess the current market penetration for various devices in different regions, which vary significantly due to consumer preferences.

RNCOS’ study thus leads to the proposition that innovation has huge scope in the field of insulin delivery and its analysts have elaborate information on some of the emerging insulin delivery devices. Finally, an analysis of the leading market players provides a holistic understanding to the reader. Players covered include Novo Nordisk, Eli Lilly, Sanofi-Aventis, Medtronic, Roche and Becton, and Dickinson and Co. These players together account for more than 90% of the global market.

Not able to find data you are looking for? Ask our Research Analyst.

media citation

get in touch

Please fill-in the information below.